Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

The Relationship between Molecular Response of BCR-ABL1 Transcripts within 6 Months and Deep Molecular Response at 18 Months to Dasatinib Treatment for Newly Diagnosed Patients with CML-CP

Daigo Michimata, MD, Kazunori Murai, MD PhD, Yasuro Miyairi, MD, PhD, Yoshiaki Okano, MD, PhD, Yuuzou Suzuki, MD, PhD, Hiroyuki Hamada, MD, Akiyoshi Sato, MD, PhD, Tatsuo Oyake, Shugo Kowata, MD, PhD, Yasuhiko Tsukushi, MD, PhD, Norifumi Sugawara, MD, PhD, Akihiro Otsu, MD, PhD, Kenji Shimosegawa, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2019) 134 (Supplement_1): 2928.

https://doi.org/10.1182/blood-2019-125066

Published: 2019

Journal Articles

Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience

Kazunori Murai, MD PhD, Hamada Hiroyuki, MD, Akiyoshi Sato, MD ,PhD, Miyairi Yasuro, MD, PhD, Yasuki Mori, MD,PhD, Tsutomu Sakuma, MD, PhD

Blood (2017) 130 (Supplement 1): 5179.

https://doi.org/10.1182/blood.V130.Suppl_1.5179.5179

Published: 2017

Journal Articles

Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Ryousei Sasaki, MD, PhD, Wataru Izumita, MD, Takahiro Mine, MD, Maki Asahi, MD, PhD, Yuzo Suzuki, MD, PhD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Yasuhiko Tsukushi, MD, PhD, Yusei Aoki, MD, Shugo Kowata, MD, PhD, Ichiro Hanamura, MD, PhD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2016) 128 (22): 1607.

https://doi.org/10.1182/blood.V128.22.1607.1607

Published: 2016

Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Blood (2016) 128 (22): 3102.

https://doi.org/10.1182/blood.V128.22.3102.3102

Published: 2016

Journal Articles

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Kazunori Murai, MD PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD PhD, Tomoaki Akagi, Kazuei Ogawa, MD PhD, Inomata Mitsue, Kuniaki Meguro, Reiko Watanabe, MD PhD, Takuto Miyagishima, MD, PhD, Kentaro Wakasa, Motohiro Shindo, MD PhD, Yasuhiko Tsukushi, MD PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD

Blood (2015) 126 (23): 4052.

https://doi.org/10.1182/blood.V126.23.4052.4052

Published: 2015

Journal Articles

Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia

Tadashi Shimoyama, MD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2014) 124 (21): 1456.

https://doi.org/10.1182/blood.V124.21.1456.1456

Published: 2014

Journal Articles

Discontinuation Of Dasatinib In Patients With CML Who Have Maintained Complete Molecular Response For At Least One Year: Results From a Prospective Discontinuation (DADI) Trial

Blood (2013) 122 (21): 3998.

https://doi.org/10.1182/blood.V122.21.3998.3998

Published: 2013

Journal Articles

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study Of Dasatinib In Chronic Phase Of Newly Diagnosed Chronic Myeloid Leukemia (CML-CP)

Blood (2013) 122 (21): 4031.

https://doi.org/10.1182/blood.V122.21.4031.4031

Published: 2013

Journal Articles

Dasatinib Induced Thrombocytopenia Might Be Due To The Inhibition Of Proplatelet Formation Of Megakaryocytes Via The Pathways Including Rho/Rock and Rac

Kazunori Murai, MD, PhD, Shugo Kowata, MD., Yukiteru Fujishima, MD, Yasuhiko Tsukushi, M.D., Takahiro Mine, MD., Tatsuo Oyake, M.D., Ph.D., Shigeki Ito, M.D., Ph.D., Yoji Ishida, M.D., Ph.D.

Blood (2013) 122 (21): 1071.

https://doi.org/10.1182/blood.V122.21.1071.1071

Published: 2013

Journal Articles

Novel Concept of Platelet Production From Megakaryocyte in Intact Bone Marrow: Proplatelet and Thick Protrusion.

Shugo Kowata, MD., Sumio Isogai, PhD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Koujiro Tohyama, PhD, Jiro Hitomi, MD, PhD, Yoji Ishida, MD, PhD

Blood (2012) 120 (21): 2300.

https://doi.org/10.1182/blood.V120.21.2300.2300

Published: 2012

Journal Articles

Ponatinib Induced Thrombocytopenia Might Inhibit Proplatelet Formation of Megakaryocytes Via the Pathways Including Rho/Rock and Rac.

Kazunori Murai, MD, PhD, Shugo Kowata, MD., Tatsuo Oyake, M.D., Ph.D., Tadashi Shimoyama, Maki Asahi, Sugawara Norifumi, Ryosei Sasaki, Suzuki Yuzo, Fujishima Yukiteru, Yasuhiko Tsukushi, M.D., Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2012) 120 (21): 2186.

https://doi.org/10.1182/blood.V120.21.2186.2186

Published: 2012

Journal Articles

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Tomoaki Akagi, MD, PhD, Kazunori Murai, MD, PhD, Kenji Shimosegawa, MD, Kenichi Ishizawa, MD, PhD, Tomohiro Sugawara, MD, Hisayuki Yokoyama, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, MD, Katsusi Tazima, MD, PhD, Koji Ooba, MD, Junichi Sakamoto, MD, PhD, Kubo Koumei, MD, PhD, Hisashi Sakamaki, MD, Hideo Harigae, MD, PhD, Yoji Ishida, MD, PhD

Blood (2011) 118 (21): 4444.

https://doi.org/10.1182/blood.V118.21.4444.4444

Published: 2011

Journal Articles

Hepatotoxicity During Eltrombopag Administration Might Be Due to Necrosis of Hepatocytes

Kazunori Murai, MD, PhD, Shugo Kowata, MD, Akiko Abo, MD, PhD, Tatsuo Oyake, M.D., Ph.D., Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2011) 118 (21): 2228.

https://doi.org/10.1182/blood.V118.21.2228.2228

Published: 2011

Journal Articles

Resveratrol Induces Cell Growth Arrest and Cell Death of Adult T-Cell Leukemia Cells Via Deacetylation of STAT3 by SIRT1

Shigeki Ito, MD, PhD, Tatsuo Oyake, MD, PhD, Kazunori Murai, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 2844.

https://doi.org/10.1182/blood.V116.21.2844.2844

Published: 2010

Journal Articles

Bortezomib Induced Thrombocytopenia Might Be Due to the Inhibition of Proplatelet Formation of Megakaryocyte.

Kazunori Murai, MD, PhD, Shugo Kowata, MD, Akiko Abo, MD, PhD, Tatsuo Oyake, MD, PhD, Kenichi Nomura, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 3696.

https://doi.org/10.1182/blood.V116.21.3696.3696

Published: 2010

Journal Articles

Forming Cytoplasmic Fragment Is Implicated In the Final Step of Platelet Production

Shugo Kowata, MD, Kazunori Murai, MD, PhD, Kenichi Nomura, MD, PhD, Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 4793.

https://doi.org/10.1182/blood.V116.21.4793.4793

Published: 2010

Journal Articles

Safety, Feasibility and Efficacy of High Dose Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) Therapy Followed by Autologous Stem Cell Transplantation for Malignant Lymphoma.

Yoshihiro Kameoka, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Ishizawa, MD, PhD, Kazunori Murai, MD, PhD, Yuichi Kato, MD, PhD, Hideyoshi Noji, MD, PhD, Jugo Ito, MD, PhD, Makoto Hirokawa, MD, PhD, Katsusi Tajima, MD, PhD, Tsutomu Shichishima, MD, PhD, Yoji Ishida, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2010) 116 (21): 4588.

https://doi.org/10.1182/blood.V116.21.4588.4588

Published: 2010

Journal Articles

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

Tatsuo Oyake, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Tomoaki Akagi, MD, PhD, Koumei Kubo, MD, PhD, Kenichi Sawada, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 1062.

https://doi.org/10.1182/blood.V116.21.1062.1062

Published: 2010

Journal Articles

Deguelin Induces Cell Growth Arrest and Cell Death Via the Suppression of BCR-ABL and Survivin Expression in BCR-ABL-T315I Mutant Cells.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2009) 114 (22): 4255.

https://doi.org/10.1182/blood.V114.22.4255.4255

Published: 2009

Journal Articles

Deguelin Induces Cell Growth Arrest and Cell Death by Destabilizing Phosphorylated STAT3 and Survivin in Adult T-Cell Leukemia Cells.

Shigeki Ito, MD, PhD, Tatsuo Oyake, MD, PhD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2009) 114 (22): 4784.

https://doi.org/10.1182/blood.V114.22.4784.4784

Published: 2009

NARROW

The Relationship between Molecular Response of BCR-ABL1 Transcripts within 6 Months and Deep Molecular Response at 18 Months to Dasatinib Treatment for Newly Diagnosed Patients with CML-CP

Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience

Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia

Discontinuation Of Dasatinib In Patients With CML Who Have Maintained Complete Molecular Response For At Least One Year: Results From a Prospective Discontinuation (DADI) Trial

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study Of Dasatinib In Chronic Phase Of Newly Diagnosed Chronic Myeloid Leukemia (CML-CP)

Dasatinib Induced Thrombocytopenia Might Be Due To The Inhibition Of Proplatelet Formation Of Megakaryocytes Via The Pathways Including Rho/Rock and Rac

Novel Concept of Platelet Production From Megakaryocyte in Intact Bone Marrow: Proplatelet and Thick Protrusion.

Ponatinib Induced Thrombocytopenia Might Inhibit Proplatelet Formation of Megakaryocytes Via the Pathways Including Rho/Rock and Rac.

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Hepatotoxicity During Eltrombopag Administration Might Be Due to Necrosis of Hepatocytes

Resveratrol Induces Cell Growth Arrest and Cell Death of Adult T-Cell Leukemia Cells Via Deacetylation of STAT3 by SIRT1

Bortezomib Induced Thrombocytopenia Might Be Due to the Inhibition of Proplatelet Formation of Megakaryocyte.

Forming Cytoplasmic Fragment Is Implicated In the Final Step of Platelet Production

Safety, Feasibility and Efficacy of High Dose Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) Therapy Followed by Autologous Stem Cell Transplantation for Malignant Lymphoma.

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

Deguelin Induces Cell Growth Arrest and Cell Death Via the Suppression of BCR-ABL and Survivin Expression in BCR-ABL-T315I Mutant Cells.

Deguelin Induces Cell Growth Arrest and Cell Death by Destabilizing Phosphorylated STAT3 and Survivin in Adult T-Cell Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only